Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr. Falk Pharma GmbH
ClinicalTrials.gov Identifier:
NCT01627262
First received: June 21, 2012
Last updated: January 20, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Primary Completion Date: August 2004 (Final data collection date for primary outcome measure)
Publications: